Market News (Page 109) - TendieTensor

Market News Page 109 of 158 • 3,936 articles

MiddleGround Capital Signs Definitive Agreement to Sell Lindsay Precast

Benzinga • Globe Newswire

MiddleGround Capital Signs Definitive Agreement to Sell Lindsay Precast

11/03/2025 08:01 AM • MiddleGround Capital has entered into a definitive agreement to sell its portfolio company Lindsay Precast to TJC, LP. Lindsay Precast is a leading manufacturer of prefabricated concrete and steel products serving infrastructure needs across various sectors in the United States.

HALO - Mentioned as provider of ENHANZE drug delivery technology used in VYVGART Hytrulo, with no specific performance details discussed
LNN - Expanded capabilities, made strategic acquisitions, and positioned for future growth under new ownership

#private equity #infrastructure #precast concrete #mergers and acquisitions

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

GlobeNewswire Inc. • Milestone Pharmaceuticals

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

11/03/2025 08:00 AM • Milestone Pharmaceuticals presented clinical trial data for etripamil nasal spray, showing consistent efficacy and safety in treating paroxysmal supraventricular tachycardia (PSVT) across multiple studies, with a New Drug Application currently under FDA review.

PFE - Demonstrated strong innovation with COVID-19 vaccine and antiviral treatment, maintaining leadership in vaccines and infectious disease research
MIST - Presented promising clinical trial results demonstrating consistent efficacy and safety of their lead investigational product, with a pending FDA New Drug Application and potential for a new treatment option in cardiovascular medicine

#etripamil #PSVT #nasal spray #clinical trials #FDA #cardiovascular

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

GlobeNewswire Inc. • Brittany Kaiser

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

11/03/2025 08:00 AM • AlphaTON Capital has partnered with PagoPay and ALT5 Sigma to launch a Mastercard payment card program enabling native cryptocurrency spending, specifically for TON tokens, with seamless digital wallet integration and global merchant acceptance.

ATON - Company is expanding its ecosystem strategy, gaining exclusive rights to market cryptocurrency cards, and creating potential new revenue streams

#cryptocurrency #Mastercard #TON #digital wallet #blockchain #payment card

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference

GlobeNewswire Inc. • Sutro Biopharma

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference

11/03/2025 08:00 AM • Sutro Biopharma will present preclinical data on advanced antibody-drug conjugates (ADCs) at the 16th Annual World ADC Conference, highlighting innovations in dual-payload ADCs and cell-free manufacturing platforms to potentially improve cancer treatment.

COVTY - Listed among competitive market players without specific performance details
STRO - Company is showcasing innovative research, presenting multiple presentations demonstrating technological advancements in ADC development, and emphasizing potential breakthroughs in cancer therapy

#ADCs #oncology #antibody drug conjugates #cancer treatment #preclinical research

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

GlobeNewswire Inc. • Sintx Technologies

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

11/03/2025 08:00 AM • SINTX Technologies launched OsseoSculpt™, a next-generation biologic designed to complement its SINAPTIC® Foot & Ankle Osteotomy Wedge System. The company recorded its first commercial revenue in Q3 2025 and plans a broader U.S. rollout through Q4 2025–Q1 2026.

DDw - Recognized as a significant player in developing advanced plastic compounds with potential for innovation
SINT - Company launched a new product, recorded initial commercial revenue, and has a strategic rollout plan for expanding market presence in the medical device sector

#OsseoSculpt #SINAPTIC #biologic #foot and ankle #osteotomy #medical device

Aeries Technology highlights AI-driven execution to accelerate enterprise transformation

GlobeNewswire Inc. • Unni Nambiar

Aeries Technology highlights AI-driven execution to accelerate enterprise transformation

11/03/2025 08:00 AM • Aeries Technology showcased its expanded AI-enabled implementation projects that improve productivity and operational efficiency across various business functions through consulting-led execution and deep functional specialization.

DD - Recognized as a significant player in developing advanced plastic compounds with potential for innovation
AERT - The company demonstrated strong capabilities in AI-powered business transformation, highlighting successful implementation projects that increased productivity, reduced operational time, and improved compliance across multiple business functions

#AI #business transformation #Global Capability Center #digital transformation #implementation

Avalyn to Participate in Multiple Upcoming Investor Conferences in November

GlobeNewswire Inc. • Globe Newswire

Avalyn to Participate in Multiple Upcoming Investor Conferences in November

11/03/2025 08:00 AM • Avalyn Pharma, a clinical-stage biopharmaceutical company, will participate in multiple healthcare investor conferences in November 2025, presenting its innovative inhaled therapies for pulmonary fibrosis treatment.

DOW - Highlighted as a major competitor with strong market presence in plastic compounding technologies
JEF - Mentioned as conference host with no specific positive or negative implications

#pulmonary fibrosis #inhaled therapies #clinical-stage #investor conferences

Recludix Pharma to Present at Two Investor Conferences in November

GlobeNewswire Inc. • Matt Caldemeyer

Recludix Pharma to Present at Two Investor Conferences in November

11/03/2025 08:00 AM • Recludix Pharma will present at two healthcare investor conferences in November 2025, highlighting their drug discovery platform focused on developing inhibitors for inflammatory diseases, with a strategic collaboration with Sanofi and plans to submit an Investigational New Drug application for STAT6 inhibitor REX-8756.

SNY - Mentioned in a strategic collaboration with Recludix for STAT6 inhibitor development, with no additional context provided

#drug discovery #inflammatory diseases #STAT6 inhibitor #investor conferences

Organoids Market to Reach USD 381.7 Million by 2034, Expanding at a Robust 18.5% CAGR | Reports Towards Healthcare

GlobeNewswire Inc. • Towards Healthcare

Organoids Market to Reach USD 381.7 Million by 2034, Expanding at a Robust 18.5% CAGR | Reports Towards Healthcare

11/03/2025 08:00 AM • The global organoids market is projected to grow from USD 82.80 million in 2025 to USD 381.7 million by 2034, expanding at an 18.5% CAGR. North America dominates the market, with key growth drivers including advancements in stem cell technology, drug discovery, and precision medicine research.

MRK - Collaborated with Promega Corporation to co-develop novel technologies for drug screening and discovery, leveraging strengths in organoids and synthetic chemistry

#organoids #stem cells #drug discovery #precision medicine #biotechnology

Spectral Capital Corporation to Exceed 300 Patent Filings in Artificial Intelligence and Quantum Computing Toward 500 Patent Goal for 2025

Benzinga • Prnewswire

Spectral Capital Corporation to Exceed 300 Patent Filings in Artificial Intelligence and Quantum Computing Toward 500 Patent Goal for 2025

11/03/2025 07:47 AM • Spectral Capital Corporation announced it will reach its goal of filing 500 patent applications by end of 2025, focusing on artificial intelligence, quantum computing, and hybrid AI-quantum architectures. The company has already crossed 300 patent filings and aims to have 1,000 patents by end of 2026.

MRK - Expanding access to therapies and showing leadership in immunotherapy and vaccine innovations
FCCN - The company is demonstrating significant technological innovation, rapid intellectual property development, and a clear strategic vision for future computing technologies, as evidenced by their ambitious patent filing goals and leadership statements

#artificial intelligence #quantum computing #patent filing #hybrid AI-quantum architectures

Coeur Mining's $7 Billion Deal For New Gold Creates $20 Billion Powerhouse

Benzinga • Stjepan Kalinic

Coeur Mining's $7 Billion Deal For New Gold Creates $20 Billion Powerhouse

11/03/2025 07:39 AM • Coeur Mining announced an all-stock acquisition of New Gold for $7 billion, creating a $20 billion North American precious metals producer with seven mines across the U.S., Canada, and Mexico.

JNJ - Maintaining diverse portfolio across pharmaceuticals, medical devices, and consumer health with steady new therapy developments
CDE - Company will own 62% of combined entity, expects $3 billion EBITDA and $2 billion free cash flow by 2026, creating a larger-scale mining powerhouse

#merger #mining #precious metals #gold #silver #acquisition

Dollar Returns, Central Banks Signal Caution, Capital Seeks Safety

Benzinga • Finit Benzinga Contributor

Dollar Returns, Central Banks Signal Caution, Capital Seeks Safety

11/03/2025 07:36 AM • Central banks like BOJ and Federal Reserve showed cautious monetary policy, causing market uncertainty. Corporate earnings remained strong, with tech companies delivering solid results, but institutional investors are moderating risk exposure.

AMZN - 9.6% stock rally on strong cloud growth and late-session institutional inflows

#monetary policy #central banks #dollar #earnings #market uncertainty

Verde Closes $2 Million Strategic Investment from Commercial Partner Ergon

Benzinga • Prnewswire

Verde Closes $2 Million Strategic Investment from Commercial Partner Ergon

11/03/2025 07:32 AM • Verde Resources secured a $2 million strategic investment from Ergon Asphalt & Emulsions, following a 10-year exclusive licensing agreement for their BioAsphalt™ technology across North America. The investment validates Verde's innovative carbon-sequestering road materials technology.

VRDR - Received significant strategic investment, secured long-term licensing agreement, validated technology performance, and gained a major industry partner

#BioAsphalt #carbon sequestration #sustainable infrastructure #road materials #investment

EXCLUSIVE: Brazil Potash Appoints Advisor To Unlock Global Funding Opportunities

Benzinga • Lekha Gupta

EXCLUSIVE: Brazil Potash Appoints Advisor To Unlock Global Funding Opportunities

11/03/2025 07:31 AM • Brazil Potash has appointed BTIG, LLC as its lead financial advisor to secure equity investment for project construction, aiming to bring in strategic partners with minimal shareholder dilution.

GRO - Company is proactively seeking funding strategies, exploring capital optimization, and partnering with a global financial advisor to support project development

#potash #investment #project funding #strategic partners

DeFi Technologies Subsidiary Stillman Digital Partners in Launch of GoDark, an Institutional Dark Pool for Digital Assets Backed by Copper and GSR

Benzinga • Prnewswire

DeFi Technologies Subsidiary Stillman Digital Partners in Launch of GoDark, an Institutional Dark Pool for Digital Assets Backed by Copper and GSR

11/03/2025 07:30 AM • DeFi Technologies' subsidiary Stillman Digital has partnered with GoDark to launch an institutional dark pool for digital assets, providing off-exchange block liquidity and low-latency trading for institutional investors.

BACpB - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
DEFT - Expanding institutional trading capabilities through strategic partnership with GoDark, demonstrating growth and innovation in digital asset markets

#DeFi #digital assets #dark pool #institutional trading #blockchain

My Favorite Dividend King to Buy in November

The Motley Fool • Keith Speights

My Favorite Dividend King to Buy in November

11/03/2025 07:30 AM • AbbVie, a pharmaceutical company with a 53-year dividend increase streak, offers strong growth potential through successful drugs like Skyrizi and Rinvoq, and an attractive valuation with a forward P/E ratio lower than the S&P 500.

BAC - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
ABBV - The article highlights AbbVie's consistent dividend growth, strong drug portfolio, promising pipeline, attractive valuation, and potential for future earnings, making it an appealing investment

#dividend #pharmaceutical #AbbVie #Skyrizi #Rinvoq #investment

1 Impressive Quantum Computing ETF I'm Strongly Considering Right Now

The Motley Fool • Matt Frankel

1 Impressive Quantum Computing ETF I'm Strongly Considering Right Now

11/03/2025 07:22 AM • The article discusses the Defiance Quantum ETF as a potential investment opportunity in the emerging quantum computing technology sector, highlighting its diversified portfolio of 79 companies and relatively low expense ratio of 0.40%.

BACpE - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
QTUM - Offers broad exposure to quantum computing stocks, has a reasonable expense ratio, and provides diversification in an early-stage technology sector

#quantum computing #ETF #technology investment #emerging tech

The Motley Fool Interviews Scott D. Anthony: Epic Disruptions

The Motley Fool • Scott D. Anthony

The Motley Fool Interviews Scott D. Anthony: Epic Disruptions

11/03/2025 07:21 AM • Scott D. Anthony discusses disruptive innovation, highlighting how successful companies transform complex and expensive technologies into simple, affordable solutions that drive market growth, using examples from Kodak, Apple, and emerging AI technologies.

BACpK - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
KODK - Failed to reimagine their business model during digital photography disruption, unable to pivot from traditional film business

#disruption #innovation #AI #business models #technology transformation

The Motley Fool • Motley Fool Staff

AI's Power Problem

11/03/2025 07:20 AM • The article discusses the massive power infrastructure challenges facing AI development, highlighting the need for significant new power generation capacity, with a particular focus on nuclear small modular reactors (SMRs) as a potential solution to meet growing energy demands from AI and data centers.

BACpL - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
SMR - Analysts view the company as overhyped, noting limited progress in reactor deployment and higher-than-expected costs that caused previous partners to withdraw

#AI #power infrastructure #nuclear energy #small modular reactors #data centers #energy demand

Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?

Benzinga • Namrata Sen

Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?

11/03/2025 07:16 AM • Kimberly-Clark announced an acquisition of Kenvue in a $48.7 billion cash and stock deal, causing significant stock price movements. The transaction aims to create a stronger commercial platform with projected annual net revenue of $32 billion by 2025.

BACpM - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
KMB - Stock plunged 16.15% in pre-market trading following the acquisition announcement, indicating market uncertainty about the deal

#acquisition #merger #stock movement #consumer products

The Motley Fool • Steven Porrello

3 Best Clean Energy Stocks to Buy Now

11/03/2025 07:05 AM • The clean energy market is projected to grow from $0.7 trillion to $1.8 trillion by 2033. Three promising companies in this sector are developing innovative clean energy solutions targeting different market segments.

BACpN - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
OKLO - Developing compact nuclear reactors for off-grid areas, backed by OpenAI's Sam Altman, with significant cash reserves and potential for commercial scale deployment

#clean energy #nuclear #fuel cells #batteries #electric vehicles

Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment

GlobeNewswire Inc. • Jody Aufrichtig

Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment

11/03/2025 07:00 AM • Psyence BioMed made a $3.5 million follow-on investment in PsyLabs, a leading producer of psychedelic pharmaceutical ingredients, to secure a sustainable and ethical supply chain for its clinical research programs in mental health therapies.

BMLpJ - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
PBM - Company is expanding strategic partnership, making significant investment, and positioning itself as a leader in psychedelic therapeutics research

#psychedelics #psilocybin #ibogaine #mental health #clinical research #investment

Multiple Myeloma Research Foundation Joins Forces with Patients and Caregivers for Road to Victories Fundraiser

GlobeNewswire Inc. • Adam Silverstein

Multiple Myeloma Research Foundation Joins Forces with Patients and Caregivers for Road to Victories Fundraiser

11/03/2025 07:00 AM • The Multiple Myeloma Research Foundation will host its 9th annual Road to Victories ride in California's Death Valley from November 5-9, 2025, raising awareness and funds for multiple myeloma research with support from Johnson & Johnson.

BMLpH - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
JNJ - Actively supporting the fundraising event, demonstrating commitment to multiple myeloma research and patient care through long-standing collaboration with MMRF

#multiple myeloma #fundraiser #research #cycling #Death Valley

Jade Biosciences to Participate in Upcoming Conferences

GlobeNewswire Inc. • Jade Biosciences

Jade Biosciences to Participate in Upcoming Conferences

11/03/2025 07:00 AM • Jade Biosciences, a clinical-stage biotechnology company, announced participation in multiple healthcare conferences in November 2025 and provided updates on its autoimmune disease therapy pipeline, including JADE101 and JADE201.

BMLpG - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
JBIO - Company is actively presenting at multiple conferences, showcasing ongoing clinical development of pipeline candidates targeting autoimmune diseases, indicating forward momentum and research progress

#biotechnology #autoimmune diseases #clinical trials #conferences #nephrology

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire Inc. • Monte Rosa Therapeutics

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

11/03/2025 07:00 AM • Monte Rosa Therapeutics announced CEO Markus Warmuth will participate in multiple healthcare investor conferences in November and December 2025, presenting the company's molecular glue degrader (MGD) research and developments.

BACpS - First Investor Day in 14 years, recent earnings beat, and potential for optimistic outlook on consumer banking and economic trends
GLUE - Company is actively presenting at multiple investor conferences, showcasing ongoing research and potential for growth in biotechnology, particularly in molecular glue degrader medicines

#molecular glue degrader #biotechnology #investor conferences #healthcare innovation